ERBB2 and ductal breast carcinoma in situ: To better understand the expression pattern of the involved genes during DCIS progression, regions of normal breast from HER2-positive breast cancer patients (NL_pos) and HER2-negative breast cancer patients (NL_neg) were also compared (Fig. 5a).